Compare MCRB & TBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCRB | TBI |
|---|---|---|
| Founded | 2010 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.7M | 129.9M |
| IPO Year | 2015 | 1995 |
| Metric | MCRB | TBI |
|---|---|---|
| Price | $9.42 | $3.63 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $14.33 | $6.00 |
| AVG Volume (30 Days) | 46.0K | ★ 273.6K |
| Earning Date | 06-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.39 |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $789,000.00 | N/A |
| Revenue This Year | N/A | $6.25 |
| Revenue Next Year | N/A | $3.90 |
| P/E Ratio | $14.28 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.36 | $3.44 |
| 52 Week High | $29.98 | $7.78 |
| Indicator | MCRB | TBI |
|---|---|---|
| Relative Strength Index (RSI) | 43.72 | 33.19 |
| Support Level | $6.99 | $3.44 |
| Resistance Level | $9.60 | $5.56 |
| Average True Range (ATR) | 0.53 | 0.24 |
| MACD | 0.24 | -0.02 |
| Stochastic Oscillator | 77.57 | 12.39 |
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
TrueBlue Inc is a provider of specialized workforce solutions that connect employers with talent. Its reportable segments include PeopleReady, which provides blue-collar contingent staffing and delivers on-demand and skilled labor across industries such as construction, transportation, retail, hospitality, and energy. The PeopleManagement segment offers contingent labor and outsourced industrial workforce solutions, mainly on-site at client facilities, through its OnSite and Centerline operations, focusing on workforce management and commercial driver services. PeopleSolutions delivers services focused on professional and specialized talent acquisition, as well as workforce management and compliance. The company generates the majority of its revenue from the PeopleReady segment.